Works by Ukropec, Jon

Results: 12

Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses.

Published in:

2020

By:

Xu, Xu Steven;
Moreau, Philippe;
Usmani, Saad Z.;
Lonial, Sagar;
Jakubowiak, Andrzej;
Oriol, Albert;
Krishnan, Amrita;
Bladé, Joan;
Luo, Man;
Sun, Yu-Nien;
Zhou, Honghui;
Nnane, Ivo;
Deraedt, William;
Qi, Ming;
Ukropec, Jon;
Clemens, Pamela L.

Publication type:

journal article

Cardiovascular and pulmonary adverse events in patients treated with BCR- ABL inhibitors: Data from the FDA Adverse Event Reporting System.

Published in:

American Journal of Hematology, 2015, v. 90, n. 4, p. E66, doi. 10.1002/ajh.23938

By:

Cortes, Jorge;
Mauro, Michael;
Steegmann, Juan Luis;
Saglio, Giuseppe;
Malhotra, Rachpal;
Ukropec, Jon A.;
Wallis, Nicola T.

Publication type:

Article

P1176: CLINICAL OUTCOMES OF NOVEL THERAPIES IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA.

Published in:

2023

By:

Crombie, Jennifer;
Jun, Monika;
Wang, Tongsheng;
Mutebi, Alex;
Wang, Anthony;
Chibber, Anindit;
Kamalakar, Rajesh;
Ukropec, Jon;
Blaedel, Julie;
Kalsekar, Anupama

Publication type:

Abstract

Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma.

Published in:

Leukemia & Lymphoma, 2024, v. 65, n. 11, p. 1623, doi. 10.1080/10428194.2024.2371472

By:

Crombie, Jennifer L.;
Jun, Monika;
Wang, Tongsheng;
Mutebi, Alex;
Wang, Anthony;
Chhibber, Anindit;
Kamalakar, Rajesh;
Ukropec, Jon;
Blaedel, Julie;
Kalsekar, Anupama

Publication type:

Article

Early M‐Protein Dynamics Predicts Progression‐Free Survival in Patients With Relapsed/Refractory Multiple Myeloma.

Published in:

CTS: Clinical & Translational Science, 2020, v. 13, n. 6, p. 1345, doi. 10.1111/cts.12836

By:

Yan, Xiaoyu;
Xu, Xu Steven;
Weisel, Katja C.;
Mateos, Maria‐Victoria;
Sonneveld, Pieter;
Dimopoulos, Meletios A.;
Usmani, Saad Zafar;
Bahlis, Nizar J.;
Puchalski, Thomas;
Ukropec, Jon;
Bellew, Kevin;
Ming, Qi;
Sun, Steven;
Zhou, Honghui

Publication type:

Article

Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma.

Published in:

2018

By:

Chari, Ajai;
Lonial, Sagar;
Mark, Tomer M.;
Krishnan, Amrita Y.;
Stockerl‐Goldstein, Keith E.;
Usmani, Saad Z.;
Londhe, Anil;
Etheredge, Delores;
Fleming, Sarah;
Liu, Baolian;
Ukropec, Jon;
Lin, Thomas S.;
Jagannath, Sundar;
Nooka, Ajay K.;
Stockerl-Goldstein, Keith E

Publication type:

journal article

Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma.

Published in:

2020

By:

Fonseca, Rafael;
Usmani, Saad Z;
Mehra, Maneesha;
Slavcev, Mary;
He, Jianming;
Cote, Sarah;
Lam, Annette;
Ukropec, Jon;
Maiese, Eric M;
Nair, Sandhya;
Potluri, Ravi;
Voorhees, Peter M

Publication type:

journal article

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.

Published in:

British Journal of Haematology, 2019, v. 185, n. 3, p. 492, doi. 10.1111/bjh.15806

By:

Yimer, Habte;
Ukropec, Jon;
Qi, Ming;
Rifkin, Robert M.;
Melear, Jason;
Faber, Edward;
Bensinger, William I.;
Burke, John M.;
Narang, Mohit;
Stevens, Don;
Gunawardena, Sriya;
Lutska, Yana;
Lin, Thomas S.;
Qi, Keqin

Publication type:

Article

Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia.

Published in:

Oncology & Therapy, 2021, v. 9, n. 1, p. 139, doi. 10.1007/s40487-020-00137-x

By:

Cook, Gordon;
Corso, Alessandro;
Streetly, Matthew;
Mendeleeva, Larisa P.;
Ptushkin, Vadim V.;
Chan, Edmond;
Ukropec, Jon;
Iraqi, Wafae;
Al-Akabawi, Assem;
Pei, Huiling;
Gaudig, Maren;
Petrucci, Maria Teresa;
Alegre, Adrian;
Mateos, Maria-Victoria

Publication type:

Article

Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. 785, doi. 10.1016/j.clml.2021.06.005

By:

Mateos, Maria-Victoria;
Dimopoulos, Meletios A.;
Cavo, Michele;
Suzuki, Kenshi;
Knop, Stefan;
Doyen, Chantal;
Lucio, Paulo;
Nagy, Zsolt;
Pour, Ludek;
Grosicki, Sebastian;
Crepaldi, Andre;
Liberati, Anna Marina;
Campbell, Philip;
Yoon, Sung-Soo;
Iosava, Genadi;
Fujisaki, Tomoaki;
Garg, Mamta;
Iida, Shinsuke;
Bladé, Joan;
Ukropec, Jon

Publication type:

Article

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR.

Published in:

2020

By:

Mateos, Maria-Victoria;
Sonneveld, Pieter;
Hungria, Vania;
Nooka, Ajay K.;
Estell, Jane A.;
Barreto, Wolney;
Corradini, Paolo;
Min, Chang-Ki;
Medvedova, Eva;
Weisel, Katja;
Chiu, Christopher;
Schecter, Jordan M.;
Amin, Himal;
Qin, Xiang;
Ukropec, Jon;
Kobos, Rachel;
Spencer, Andrew

Publication type:

journal article

Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma After Frontline Transplant: A Multicenter, Randomized, Phase 3 Study (AURIGA).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e199, doi. 10.1016/j.clml.2019.09.332

By:

Lin, Thomas;
Hampras, Shalaka;
Krey, Ryan;
Pei, Huiling;
Qi, Ming;
Krevvata, Maria;
Kane, Colleen;
Lutska, Yana;
Ryland, Katherine;
Chiu, Chris;
Ukropec, Jon;
Shah, Nina

Publication type:

Article